Block on Trump's Asylum Ban Upheld by Supreme Court
Johnson & Johnson is beginning to outstrip even Toyota in the amount of recalls the company has had to face in a single year. This week, yet another recall for a J&J product was announced. Due to a musty or moldy odor, the company is recalling an additional lot of Tylenol painkillers.
According to a report by Reuters, the company is engaging in a voluntary Tylenol recall of the affected product even though the "risk of adverse medical events is remote," said a company statement. The specific type of Tylenol subject to the recall is adult Tylenol eight-hour caplets sold in 50-count bottles in both the United States and Puerto Rico.
A company spokeswoman has confirmed that the drugs which are part of this Tylenol recall were made in a McNeil Consumer Healthcare Unit plant located in Fort Washington, Pennsylvania. This is the same plant that was cited earlier in the year by the FDA for violations of good manufacturing practice requirements. Reuters reports that products from the McNeil plant account for about 1 percent of total annual Johnson & Johnson sales.
Over and over, Tylenol and Motrin products have been the subject of the recalls dogging J&J. Some of the recalls have been due to complaints of musty or moldy odors emanating from the drugs. Reuters reports the smell was found to be a chemical called 2,4,6-tribromoanisole, which is present in the wooden pallets that product packaging materials are moved and stored on.
When asked if she though any further recalls would be on the horizon for the beleaguered company, the Johnson & Johnson spokeswoman answered, "I can't speculate."